The concept of tissue banking as a "bio-repository" aimed to collection, storing and distribution of human biological material and clinical information, is emerging as a successful strategy to support clinical and translational research. In particular, Tumor Biobanks represent a key resource for diagnosis, research and experimental therapies, especially for those correlated to clinical application of a new type of medicine known as "intelligent drugs". Biobanks are not "spontaneous" collections, but they needs an institutional organization, basically a research unit, whose effectiveness and quality can be guaranteed only if it is carefully organized according to precise and shared rules.
No takes yet. Share an insight, caveat, or question.
Botti et al. (2012) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: